Exploring bisbenzimidazole-chalcone hybrid compounds: Dual-action as antibacterial agents targeting biofilm formation and E. coli DNA gyrase inhibition

Basit Öğe Kaydı
dc.contributor.authorAdal, Ercan
dc.contributor.authorOksuz, Zehra
dc.contributor.authorOzkul, Ceren
dc.contributor.authorNigiz, Seyma
dc.contributor.authorAlagoz, M. Abdulah
dc.contributor.authorDogen, Aylin
dc.contributor.authorSimsek, Rahime
dc.date.accessioned2026-04-04T13:34:54Z
dc.date.available2026-04-04T13:34:54Z
dc.date.issued2025
dc.departmentİnönü Üniversitesi
dc.description.abstractThe emergence of antibiotic-resistant pathogens has reduced the efficacy of current antimicrobial therapies, emphasizing the need for new therapeutic agents. This study presents the design, synthesis, and evaluation of bisbenzimidazole-chalcone hybrid compounds as potential antimicrobial agents. These compounds were tested for their antimicrobial activity against eleven common pathogens, as well as their ability to inhibit biofilm formation and eradicate preformed biofilms in Escherichia coli. Compounds EA1, EA3, EA4, and EA5 demonstrated antibacterial activity against E. coli comparable to ampicillin (31.25 mu g/mL) and outperformed the other tested compounds. Notably, EA4 and EA5 inhibited biofilm formation at sub-MIC concentrations and effectively eradicated preformed biofilms, as confirmed by the crystal violet assay. The synergistic effects of the most active compounds in combination with ampicillin were assessed using checkerboard synergy testing, with all combinations showing 'indifference' effects. Further analysis of the most potent compounds against E. coli ATCC 25,922 included the inhibition of DNA gyrase using E. coli DNA gyrase and a plasmid-based relaxed DNA kit. Molecular docking and molecular dynamics simulations were conducted to elucidate the binding modes and stability of these compounds within E. coli DNA gyrase enzymes. EA4 exhibited significant affinity for DNA gyrase B subunit (docking score: -4.026 kcal/mol, average RMSD value: 4.4 & Aring;), while EA5 displayed dual affinity for both DNA gyrase B subunit and DNA gyrase A subunit (docking scores: -6.944 and -3.432 kcal/mol, respectively), maintaining stable interactions in the active sites during simulations (average RMSD values of 3.2 & Aring; and 3.1 & Aring;). These results highlight the potential of bisbenzimidazole-chalcone hybrids as promising antibacterial agents, particularly in their dualtargeting capabilities against biofilm formation and DNA gyrase inhibition.
dc.identifier.doi10.1016/j.molstruc.2025.142375
dc.identifier.issn0022-2860
dc.identifier.issn1872-8014
dc.identifier.orcid0000-0002-8354-5107
dc.identifier.scopus2-s2.0-105002490662
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2025.142375
dc.identifier.urihttps://hdl.handle.net/11616/109482
dc.identifier.volume1338
dc.identifier.wosWOS:001473769200001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Molecular Structure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.subjectBisbenzimidazole
dc.subjectChalcone
dc.subjectHybrid compounds
dc.subjectAntibacterial activity
dc.subjectBiofilm
dc.subjectInhibition
dc.subjectDNA gyrase inhibition
dc.titleExploring bisbenzimidazole-chalcone hybrid compounds: Dual-action as antibacterial agents targeting biofilm formation and E. coli DNA gyrase inhibition
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu